Catalyst Pharmaceuticals, Inc.
Символ: CPRX
NASDAQ
15.12
USDПазарна цена днес
22.5953
Съотношение P/E
-0.3697
Коефициент PEG
1.78B
MRK Cap
- 0.00%
Доходност на DIV
Catalyst Pharmaceuticals, Inc. (CPRX) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2002 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 585.64 | 137.6 | 298.4 | 191.3 | |||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 19.8 | |||||||||||||||||||||
balance-sheet.row.net-receivables | 177.76 | 53.5 | 10.4 | 6.6 | |||||||||||||||||||||
balance-sheet.row.inventory | 45.76 | 15.6 | 6.8 | 7.9 | |||||||||||||||||||||
balance-sheet.row.other-current-assets | 20.18 | 12.5 | 5.2 | 4.4 | |||||||||||||||||||||
balance-sheet.row.total-current-assets | 851.23 | 219.3 | 320.8 | 210.1 | |||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 15.3 | 3.7 | 3.6 | 4 | |||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.intangible-assets | 720.84 | 194 | 32.5 | 0 | |||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 720.84 | 194 | 32.5 | 0 | |||||||||||||||||||||
balance-sheet.row.long-term-investments | 396.9 | 16.5 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.tax-assets | 119.5 | 38.3 | 18.7 | 23.7 | |||||||||||||||||||||
balance-sheet.row.other-non-current-assets | -367.51 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 885.02 | 252.6 | 54.8 | 27.7 | |||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-assets | 1736.24 | 471.9 | 375.6 | 237.8 | |||||||||||||||||||||
balance-sheet.row.account-payables | 27.2 | 14.8 | 4 | 2.8 | |||||||||||||||||||||
balance-sheet.row.short-term-debt | 1.43 | 0.4 | 0.3 | 0.3 | |||||||||||||||||||||
balance-sheet.row.tax-payables | 24.14 | 0.7 | 8.7 | 0.1 | |||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 13.31 | 3.2 | 3.6 | 3.9 | |||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | -1.3 | 0 | |||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 1.79 | - | - | - | |||||||||||||||||||||
balance-sheet.row.other-current-liab | 113.97 | 60.2 | 53.3 | 0.2 | |||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 47.78 | 8 | 17.6 | 3.9 | |||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 14.03 | 3.2 | 3.6 | 3.9 | |||||||||||||||||||||
balance-sheet.row.total-liab | 290.86 | 84 | 75.2 | 31 | |||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.common-stock | 0.43 | 0.1 | 0.1 | 0.1 | |||||||||||||||||||||
balance-sheet.row.retained-earnings | 404.32 | 121.3 | 49.9 | -26.3 | |||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0.06 | 0 | 0 | -0.1 | |||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 1040.58 | 266.5 | 250.4 | 233.2 | |||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 1445.38 | 387.9 | 300.4 | 206.8 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 1736.24 | 471.9 | 375.6 | 237.8 | |||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-equity | 1445.38 | 387.9 | 300.4 | 206.8 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 1736.24 | - | - | - | |||||||||||||||||||||
Total Investments | 396.9 | 16.5 | 0 | 19.8 | |||||||||||||||||||||
balance-sheet.row.total-debt | 14.4 | 3.6 | 3.9 | 3.9 | |||||||||||||||||||||
balance-sheet.row.net-debt | -571.24 | -134.1 | -294.5 | -167.6 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 71.41 | 71.4 | 83.1 | 39.5 | ||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 32.88 | 33.1 | 1.2 | 0.2 | ||||||||||||||||||||
cash-flows.row.deferred-income-tax | -17.82 | -17.8 | 4.9 | 9.3 | ||||||||||||||||||||
cash-flows.row.stock-based-compensation | 14.25 | 14.3 | 7.9 | 6.1 | ||||||||||||||||||||
cash-flows.row.change-in-working-capital | -37.32 | -37.3 | 13.7 | 5 | ||||||||||||||||||||
cash-flows.row.account-receivables | -43.08 | -43.1 | -3.8 | -0.6 | ||||||||||||||||||||
cash-flows.row.inventory | -4.74 | -4.7 | 1.1 | -3.2 | ||||||||||||||||||||
cash-flows.row.account-payables | 10.82 | 10.8 | 1.2 | -1.5 | ||||||||||||||||||||
cash-flows.row.other-working-capital | 25.34 | -0.3 | 15.3 | 10.4 | ||||||||||||||||||||
cash-flows.row.other-non-cash-items | 80.2 | 79.9 | 5.2 | 0.3 | ||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 143.6 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -115.52 | -198.5 | 0 | -1 | ||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 10 | 0 | ||||||||||||||||||||
cash-flows.row.purchases-of-investments | -13.46 | -13.5 | -10 | -10 | ||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 19.2 | 0 | ||||||||||||||||||||
cash-flows.row.other-investing-activites | -243.81 | -81.5 | -10 | 0 | ||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -293.5 | -293.5 | 9.2 | -11 | ||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.common-stock-issued | 2.79 | 2.8 | 4.1 | 4.1 | ||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -6.9 | -12.1 | ||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.other-financing-activites | -13.65 | -13.6 | 4.5 | -0.2 | ||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -10.86 | -10.9 | 1.7 | -8.1 | ||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.net-change-in-cash | -160.76 | -160.8 | 127 | 41.2 | ||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 585.64 | 137.6 | 298.4 | 171.4 | ||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 746.4 | 298.4 | 171.4 | 130.2 | ||||||||||||||||||||
cash-flows.row.operating-cash-flow | 143.6 | 143.6 | 116 | 60.4 | ||||||||||||||||||||
cash-flows.row.capital-expenditure | -115.52 | -198.5 | 0 | -1 | ||||||||||||||||||||
cash-flows.row.free-cash-flow | 28.08 | -54.9 | 116 | 59.4 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 398.2 | 398.2 | 214.2 | 140.8 | ||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 61.03 | 84.5 | 34.4 | 21.9 | ||||||||||||||||||||||
income-statement-row.row.gross-profit | 337.18 | 313.7 | 179.8 | 118.9 | ||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
income-statement-row.row.research-development | 93.15 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 47.02 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 86.69 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.other-expenses | 12.53 | 7.7 | 2.9 | 0.3 | ||||||||||||||||||||||
income-statement-row.row.operating-expenses | 250.37 | 226.9 | 78 | 66.6 | ||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 311.39 | 311.4 | 112.4 | 88.4 | ||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 0 | 3.6 | 0.3 | ||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | -4.1 | 0 | ||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 86.69 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 7.7 | 7.7 | 2.9 | 0.3 | ||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 12.53 | 7.7 | 2.9 | 0.3 | ||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 7.7 | 7.7 | 2.9 | 0.3 | ||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | -4.1 | 0 | ||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 32.81 | 33.1 | 1.2 | 0.2 | ||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 119.62 | - | - | - | ||||||||||||||||||||||
income-statement-row.row.operating-income | 86.81 | 86.8 | 101.8 | 52.4 | ||||||||||||||||||||||
income-statement-row.row.income-before-tax | 94.51 | 94.5 | 104.7 | 52.7 | ||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 23.1 | 23.1 | 21.6 | 13.2 | ||||||||||||||||||||||
income-statement-row.row.net-income | 71.41 | 71.4 | 83.1 | 39.5 |
Често задавани въпроси
Какво е Catalyst Pharmaceuticals, Inc. (CPRX) общи активи?
Catalyst Pharmaceuticals, Inc. (CPRX) общите активи са 471907000.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 213256000.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е 0.263.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е 0.263.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е 0.179.
Какъв е общият приход на предприятието?
Общият приход е 0.218.
Каква е Catalyst Pharmaceuticals, Inc. (CPRX) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е 71410000.000.
Какъв е общият дълг на фирмата?
Общият дълг е 3557000.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 226860000.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 137636000.000.